Daniel R. Faga
2017
In 2017, Daniel R. Faga earned a total compensation of $2.2M as Chief Business Officer at Spark Therapeutics, a 52% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $226,320 |
|---|---|
| Salary | $400,616 |
| Stock Awards | $1,543,824 |
| Other | $37,532 |
| Total | $2,208,292 |
Faga received $1.5M in stock awards, accounting for 70% of the total pay in 2017.
Faga also received $226.3K in non-equity incentive plan, $400.6K in salary and $37.5K in other compensation.
Rankings
In 2017, Daniel R. Faga's compensation ranked 5,038th out of 14,666 executives tracked by ExecPay. In other words, Faga earned more than 65.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,038 out of 14,666 | 66th |
Division Manufacturing | 1,796 out of 5,768 | 69th |
Major group Chemicals And Allied Products | 530 out of 2,074 | 74th |
Industry group Drugs | 409 out of 1,730 | 76th |
Industry Biological Products, Except Diagnostic Substances | 73 out of 316 | 77th |
Source: SEC filing on April 20, 2018.
Faga's colleagues
We found five more compensation records of executives who worked with Daniel R. Faga at Spark Therapeutics in 2017.
2017
Jeffrey Marrazzo
Spark Therapeutics
Chief Executive Officer
2017
Katherine High
Spark Therapeutics
President and Head of Research and Development
2017
Stephen Webster
Spark Therapeutics
Chief Financial Officer
2017
Joseph Barge
Spark Therapeutics
Chief Legal Officer
2017
John Furey
Spark Therapeutics